Income Statement Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-02-06 pm EST			5-day change	1st Jan Change
61.99 ^USD	+4.15%		+12.61%	+14.92%

Feb. 06	Wells Fargo Adjusts Bristol-Myers Squibb PT to $60 From $55, Maintains Equal Weight Rating	MT
Feb. 06	Citigroup Adjusts Bristol-Myers Squibb PT to $64 From $60, Maintains Neutral Rating	MT

70ddf1d859db8a5.7uYL2KeJ6VwZJoxMCInItOx-BJHJuin2IZBL1Jnrvno.2K9ln57zpDkqd9s7XNz7hdk4daCrjUGXVeE6mMCe9EmcllmT6dvdEF584w

Published financial data: BRISTOL-MYERS SQUIBB COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	42.52B	46.38B	46.16B	45.01B	48.3B
Total Revenues	42.52B	46.38B	46.16B	45.01B	48.3B
Cost of Goods Sold, Total	8.47B	9.34B	9.78B	10.52B	11.95B
Gross Profit	34.04B	37.05B	36.38B	34.49B	36.35B
Selling General & Admin Expenses, Total	7.37B	7.67B	7.7B	7.68B	7.86B
R&D Expenses	9.24B	9.53B	9.2B	9.11B	9.78B
Amortization of Goodwill and Intangible Assets - (IS)	9.69B	10.02B	9.6B	9.05B	8.87B
Other Operating Expenses, Total	26.29B	27.23B	26.5B	25.84B	26.52B
Operating Income	7.75B	9.82B	9.88B	8.65B	9.83B
Interest Expense, Total	-1.38B	-1.29B	-1.15B	-1.16B	-1.96B
Interest And Investment Income	121M	39M	171M	449M	478M
Net Interest Expenses	-1.26B	-1.25B	-982M	-712M	-1.48B
Income (Loss) On Equity Invest.	72M	231M	-108M	-38M	44M
Currency Exchange Gains (Loss)	23M	21M	96M	160M	31M
Other Non Operating Income (Expenses)	1.48B	1.66B	1.82B	2.08B	1.48B
EBT, Excl. Unusual Items	8.07B	10.48B	10.7B	10.14B	9.91B
Restructuring Charges	-690M	-187M	-144M	-535M	-867M
Merger & Related Restructuring Charges	-4B	-831M	-863M	-326M	-1.1B
Gain (Loss) On Sale Of Investments	1.16B	514M	-693M	-122M	-28M
Gain (Loss) On Sale Of Assets	62M	9M	211M	-	-15M
Asset Writedown	-1.07B	-1.16B	-98M	-107M	-2.82B
In Process R&D Expenses	-11.44B	-	-815M	-913M	-13.37B
Legal Settlements	194M	-82M	-178M	-10M	-84M
Other Unusual Items	846M	-647M	-410M	313M	-
EBT, Incl. Unusual Items	-6.87B	8.1B	7.71B	8.44B	-8.38B
Income Tax Expense	2.12B	1.08B	1.37B	400M	554M
Earnings From Continuing Operations	-9B	7.01B	6.34B	8.04B	-8.93B
Net Income to Company	-9B	7.01B	6.34B	8.04B	-8.93B
Minority Interest	-20M	-20M	-18M	-15M	-15M
Net Income - (IS)	-9.02B	6.99B	6.33B	8.02B	-8.95B
Net Income to Common Incl Extra Items	-9.02B	6.99B	6.33B	8.02B	-8.95B
Net Income to Common Excl. Extra Items	-9.02B	6.99B	6.33B	8.02B	-8.95B
Per Share Items
Net EPS - Basic	-3.99	3.15	2.97	3.88	-4.41
Basic EPS - Continuing Operations	-3.99	3.15	2.97	3.88	-4.41
Basic Weighted Average Shares Outstanding	2.26B	2.22B	2.13B	2.07B	2.03B
Net EPS - Diluted	-3.99	3.12	2.95	3.86	-4.41
Diluted EPS - Continuing Operations	-3.99	3.12	2.95	3.86	-4.41
Diluted Weighted Average Shares Outstanding	2.26B	2.24B	2.15B	2.08B	2.03B
Normalized Basic EPS	2.22	2.94	3.13	3.06	3.05
Normalized Diluted EPS	2.22	2.91	3.11	3.04	3.05
Dividend Per Share	1.84	2.01	2.19	2.31	2.42
Payout Ratio	-45.2	62.85	73.24	59.12	-54.35
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	18.18B	20.58B	20.16B	18.42B	19.41B
EBITA	17.65B	20.02B	19.58B	17.85B	18.83B
EBIT	7.75B	9.82B	9.88B	8.65B	9.83B
EBITDAR	18.44B	20.85B	20.45B	18.82B	19.76B
Total Revenues (As Reported)	42.52B	46.38B	46.16B	45.01B	48.3B
Effective Tax Rate - (Ratio)	-30.91	13.39	17.74	4.74	-6.61
Current Domestic Taxes	1.24B	1.88B	3.02B	2.74B	1.28B
Current Foreign Taxes	-104M	598M	1.09B	943M	1.36B
Total Current Taxes	1.14B	2.48B	4.11B	3.69B	2.64B
Deferred Domestic Taxes	229M	-1.26B	-2.89B	-2.34B	-2.18B
Deferred Foreign Taxes	754M	-138M	151M	-949M	96M
Total Deferred Taxes	983M	-1.39B	-2.74B	-3.29B	-2.09B
Normalized Net Income	5.02B	6.53B	6.67B	6.32B	6.18B
Interest Capitalized	-	-	-	-	-
Non-Cash Pension Expense	-6M	-23M	27M	11M	15M
Supplemental Operating Expense Items
Advertising Expense	990M	1.3B	1.3B	1.4B	1.5B
Selling and Marketing Expenses	990M	1.3B	1.3B	1.4B	1.5B
Research And Development Expense From Footnotes	22.58B	11.35B	10.32B	10.21B	24.53B
Net Rental Expense, Total	259M	274M	293M	405M	352M
Imputed Operating Lease Interest Expense	57.68M	58.22M	62.55M	91.36M	119M
Imputed Operating Lease Depreciation	201M	216M	230M	314M	233M
Stock-Based Comp., COGS (Total)	37M	57M	41M	51M	57M
Stock-Based Comp., R&D Exp. (Total)	339M	272M	221M	252M	248M
Stock-Based Comp., SG&A Exp. (Total)	332M	241M	195M	215M	202M
Stock-Based Comp., Other (Total)	71M	13M	-	-	-
Total Stock-Based Compensation	779M	583M	457M	518M	507M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	14.55B	13.98B	9.12B	11.46B	10.35B
Short Term Investments	1.9B	3.24B	130M	816M	513M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	16.45B	17.22B	9.25B	12.28B	10.86B
Accounts Receivable, Total	8.5B	9.73B	10.39B	11.34B	11.13B
Other Receivables	-	2.79B	3.55B	3.93B	3.29B
Total Receivables	8.5B	12.52B	13.94B	15.26B	14.42B
Inventory	2.07B	2.1B	2.34B	2.66B	2.56B
Prepaid Expenses	-	-	-	-	-
Restricted Cash	89M	140M	148M	55M	-
Other Current Assets, Total	3.08B	1.29B	1.6B	1.51B	1.94B
Total Current Assets	30.19B	33.26B	27.27B	31.77B	29.78B
Gross Property Plant And Equipment	10.33B	11B	11.64B	12.84B	13.31B
Accumulated Depreciation	-3.58B	-4.03B	-4.16B	-4.8B	-4.95B
Net Property Plant And Equipment	6.74B	6.97B	7.48B	8.04B	8.36B
Long-term Investments	4.51B	2.71B	2.19B	2.06B	2.06B
Goodwill	20.55B	20.5B	21.15B	21.17B	21.72B
Other Intangibles, Total	53.24B	42.53B	35.86B	27.07B	23.31B
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.16B	1.44B	1.34B	2.77B	4.24B
Deferred Charges Long-Term	-	248M	496M	413M	336M
Other Long-Term Assets, Total	2.08B	1.66B	1.04B	1.87B	2.81B
Total Assets	118B	109B	96.82B	95.16B	92.6B
Liabilities
Accounts Payable, Total	2.71B	2.95B	3.04B	3.26B	3.6B
Accrued Expenses, Total	9.42B	9.94B	10.24B	11.04B	13.13B
Short-term Borrowings	340M	184M	367M	246M	218M
Current Portion of Long-Term Debt	2B	4.76B	3.9B	2.87B	1.83B
Current Portion of Leases	164M	169M	136M	162M	181M
Current Income Taxes Payable	647M	754M	942M	1.37B	1.51B
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	3.8B	3.11B	3.27B	3.31B	3.3B
Total Current Liabilities	19.08B	21.87B	21.89B	22.26B	23.77B
Long-Term Debt	48.35B	39.6B	35.16B	36.71B	47.66B
Long-Term Leases	833M	874M	1.26B	1.53B	1.37B
Unearned Revenue Non Current	357M	326M	283M	300M	230M
Pension & Other Post Retirement Benefits	899M	654M	402M	480M	400M
Deferred Tax Liability Non Current	5.41B	4.5B	2.17B	338M	369M
Other Non Current Liabilities	5.68B	5.48B	4.54B	4.05B	2.41B
Total Liabilities	80.6B	73.31B	65.7B	65.67B	76.22B
Common Stock, Total	292M	292M	292M	292M	292M
Additional Paid In Capital	44.32B	44.36B	45.16B	45.68B	46.02B
Retained Earnings	21.28B	23.82B	25.5B	28.77B	14.91B
Treasury Stock	-26.24B	-31.26B	-38.62B	-43.77B	-43.66B
Comprehensive Income and Other	-1.84B	-1.27B	-1.28B	-1.55B	-1.24B
Total Common Equity	37.82B	35.95B	31.06B	29.43B	16.34B
Minority Interest	60M	60M	57M	55M	53M
Total Equity	37.88B	36.01B	31.12B	29.48B	16.39B
Total Liabilities And Equity	118B	109B	96.82B	95.16B	92.6B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.24B	2.18B	2.1B	2.02B	2.03B
ECS Total Common Shares Outstanding	2.24B	2.18B	2.1B	2.02B	2.03B
Book Value / Share	16.85	16.52	14.81	14.56	8.05
Tangible Book Value	-35.97B	-27.08B	-25.95B	-18.81B	-28.69B
Tangible Book Value Per Share	-16.03	-12.45	-12.37	-9.31	-14.14
Total Debt	51.68B	45.6B	40.82B	41.52B	51.26B
Net Debt	34.8B	28.38B	31.57B	28.88B	40.08B
Debt Equivalent of Unfunded Proj. Benefit Obligation	435M	120M	-51M	26M	18M
Debt Equivalent Oper. Leases	2.07B	2.19B	2.34B	3.24B	2.82B
Minority Interest, Total (Incl. Fin. Div)	60M	60M	57M	55M	53M
Equity Method Investments, Total	549M	666M	546M	542M	598M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	189M	169M	162M	162M	161M
Buildings, Total	5.73B	5.9B	5.92B	6.5B	6.58B
Machinery, Total	3.06B	3.25B	3.28B	3.72B	3.82B
Full Time Employees	30.25K	32.2K	34.3K	34.1K	34.1K
Accumulated Allowance for Doubtful Accounts (Supple)	18M	21M	22M	23M	45M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-9.02B	6.99B	6.33B	8.02B	-8.95B
Depreciation & Amortization - CF	533M	557M	582M	569M	575M
Amortization of Goodwill and Intangible Assets - (CF)	9.9B	10.2B	9.7B	9.2B	9B
Depreciation & Amortization, Total	10.43B	10.76B	10.28B	9.77B	9.58B
Minority Interest in Earnings - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-699M	-684M	-231M	-22M	-15M
(Gain) Loss on Sale of Investments - (CF)	-1.23B	-745M	801M	160M	-16M
Asset Writedown & Restructuring Costs	12.69B	1.21B	184M	1.21B	16.41B
Stock-Based Compensation (CF)	779M	583M	457M	518M	507M
Other Operating Activities, Total	105M	-654M	-2.52B	-3.89B	-3.14B
Change In Accounts Receivable	-646M	-1.05B	-663M	-995M	264M
Change In Inventories	2.67B	13M	-69M	-751M	-486M
Change In Accounts Payable	188M	245M	109M	198M	184M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	-2.3B	-1.06B	-1.42B	-603M	-1.26B
Change in Other Net Operating Assets	1.07B	606M	-183M	237M	2.11B
Cash from Operations	14.05B	16.21B	13.07B	13.86B	15.19B
Capital Expenditure	-753M	-973M	-1.12B	-1.21B	-1.25B
Cash Acquisitions	-13.08B	-1.61B	-4.29B	-1.17B	-21.82B
Divestitures	870M	748M	1.3B	909M	1.1B
Investment in Marketable and Equity Securities, Total	2.11B	1.3B	3.04B	-826M	618M
Cash from Investing	-10.86B	-538M	-1.06B	-2.3B	-21.35B
Short Term Debt Issued, Total	-	-	194M	-	3.09B
Long-Term Debt Issued, Total	6.94B	-	5.93B	4.46B	12.88B
Total Debt Issued	6.94B	-	6.12B	4.46B	15.97B
Short Term Debt Repaid, Total	-267M	-160M	-	-120M	-3B
Long-Term Debt Repaid, Total	-2.75B	-6.02B	-11.43B	-3.88B	-2.87B
Total Debt Repaid	-3.02B	-6.18B	-11.43B	-4B	-5.87B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.55B	-6.29B	-8B	-5.16B	-
Common Dividends Paid	-4.08B	-4.4B	-4.63B	-4.74B	-4.86B
Common & Preferred Stock Dividends Paid	-4.08B	-4.4B	-4.63B	-4.74B	-4.86B
Other Financing Activities, Total	542M	641M	984M	27M	-106M
Cash from Financing	-1.15B	-16.22B	-16.96B	-9.42B	5.13B
Foreign Exchange Rate Adjustments	111M	-102M	-33M	45M	-137M
Net Change in Cash	2.15B	-657M	-4.99B	2.19B	-1.17B
Supplemental Items
Cash Interest Paid	1.6B	1.5B	1.4B	1.2B	1.8B
Cash Income Tax Paid (Refund)	3.4B	3.5B	5.4B	4.3B	3.9B
Levered Free Cash Flow	16.41B	13.57B	13.83B	13.78B	16.89B
Unlevered Free Cash Flow	17.27B	14.38B	14.56B	14.51B	18.11B
Change In Net Working Capital	-1.97B	2.12B	1.24B	-21M	-3.14B
Net Debt Issued / Repaid	3.93B	-6.18B	-5.31B	456M	10.1B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.9	5.39	5.99	5.63	6.55
Return on Total Capital	5.13	7.17	8.04	7.56	8.86
Return On Equity %	-20.08	18.99	18.91	26.53	-38.95
Return on Common Equity	-20.16	18.96	18.88	26.53	-39.1
Margin Analysis
Gross Profit Margin %	80.07	79.87	78.81	76.63	75.26
SG&A Margin	17.33	16.54	16.69	17.06	16.28
EBITDA Margin %	42.77	44.37	43.68	40.93	40.18
EBITA Margin %	41.51	43.16	42.42	39.66	38.99
EBIT Margin %	18.23	21.17	21.4	19.22	20.36
Income From Continuing Operations Margin %	-21.16	15.12	13.75	17.86	-18.49
Net Income Margin %	-21.2	15.08	13.71	17.83	-18.53
Net Avail. For Common Margin %	-21.2	15.08	13.71	17.83	-18.53
Normalized Net Income Margin	11.81	14.07	14.45	14.05	12.79
Levered Free Cash Flow Margin	38.6	29.26	29.97	30.62	34.97
Unlevered Free Cash Flow Margin	40.63	31.01	31.53	32.23	37.5
Asset Turnover
Asset Turnover	0.34	0.41	0.45	0.47	0.51
Fixed Assets Turnover	6.21	6.77	6.39	5.8	5.89
Receivables Turnover (Average Receivables)	5.25	5.02	4.59	4.14	4.3
Inventory Turnover (Average Inventory)	2.66	4.48	4.41	4.21	4.58
Short Term Liquidity
Current Ratio	1.58	1.52	1.25	1.43	1.25
Quick Ratio	1.31	1.36	1.06	1.24	1.06
Operating Cash Flow to Current Liabilities	0.74	0.74	0.6	0.62	0.64
Days Sales Outstanding (Average Receivables)	69.67	72.73	79.55	88.1	85.13
Days Outstanding Inventory (Average Inventory)	137.51	81.49	82.73	86.77	79.93
Average Days Payable Outstanding	150.93	110.42	109.03	106.04	106.01
Cash Conversion Cycle (Average Days)	56.25	43.79	53.25	68.84	59.05
Long Term Solvency
Total Debt/Equity	136.43	126.63	131.18	140.82	312.77
Total Debt / Total Capital	57.7	55.88	56.74	58.48	75.77
LT Debt/Equity	129.82	112.42	117.04	129.69	299.18
Long-Term Debt / Total Capital	54.91	49.61	50.63	53.85	72.48
Total Liabilities / Total Assets	68.03	67.06	67.86	69.02	82.3
EBIT / Interest Expense	5.61	7.6	8.57	7.45	5.02
EBITDA / Interest Expense	13.35	16.14	17.74	16.21	10.09
(EBITDA - Capex) / Interest Expense	12.81	15.39	16.77	15.17	9.45
Total Debt / EBITDA	2.8	2.19	2	2.21	2.59
Net Debt / EBITDA	1.89	1.36	1.54	1.53	2.03
Total Debt / (EBITDA - Capex)	2.92	2.29	2.11	2.36	2.77
Net Debt / (EBITDA - Capex)	1.97	1.43	1.63	1.64	2.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	62.62	9.09	-0.49	-2.5	7.32
Gross Profit, 1 Yr. Growth %	79.89	8.82	-1.81	-5.2	5.4
EBITDA, 1 Yr. Growth %	106.14	13.17	-2.97	-8.64	5.36
EBITA, 1 Yr. Growth %	110.13	13.43	-3.18	-8.83	5.5
EBIT, 1 Yr. Growth %	9.17	26.72	-1.42	-12.43	13.65
Earnings From Cont. Operations, 1 Yr. Growth %	-359.97	-177.98	-9.54	26.71	-211.11
Net Income, 1 Yr. Growth %	-362.14	-177.58	-9.54	26.84	-211.5
Normalized Net Income, 1 Yr. Growth %	-2.6	29.9	-0.2	-5.23	-2.68
Diluted EPS Before Extra, 1 Yr. Growth %	-298.63	-178.15	-5.45	30.85	-214.36
Accounts Receivable, 1 Yr. Growth %	10.62	11.14	6.78	9.11	-1.81
Inventory, 1 Yr. Growth %	-51.69	1.01	11.65	13.81	-3.94
Net Property, Plant and Equip., 1 Yr. Growth %	-3.03	3.31	7.28	7.5	4.03
Total Assets, 1 Yr. Growth %	-8.82	-7.74	-11.43	-1.72	-2.69
Tangible Book Value, 1 Yr. Growth %	3.18	-24.7	-4.19	-27.5	52.52
Common Equity, 1 Yr. Growth %	-26.7	-4.96	-13.59	-5.25	-44.5
Cash From Operations, 1 Yr. Growth %	71.16	15.34	-19.38	6.08	9.6
Capital Expenditures, 1 Yr. Growth %	-9.93	29.22	14.9	8.14	3.23
Levered Free Cash Flow, 1 Yr. Growth %	170.25	-17.28	0.99	-0.16	22.57
Unlevered Free Cash Flow, 1 Yr. Growth %	160.4	-16.74	0.34	-0.34	24.87
Dividend Per Share, 1 Yr. Growth %	9.52	9.24	8.96	5.48	4.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	37.28	33.2	4.19	-1.5	2.29
Gross Profit, 2 Yr. CAGR %	45.19	42.49	8.78	-2.72	0.46
EBITDA, 2 Yr. CAGR %	76.04	62.45	20.76	-2.38	-0.04
EBITA, 2 Yr. CAGR %	79.54	64.75	21.37	-2.48	-0.02
EBIT, 2 Yr. CAGR %	21.18	27.13	70.68	0.46	3.71
Earnings From Cont. Operations, 2 Yr. CAGR %	34.84	42.38	-16.01	7.06	18.65
Net Income, 2 Yr. CAGR %	35.36	42.61	-16.22	7.12	18.92
Normalized Net Income, 2 Yr. CAGR %	10.56	21.4	69.35	4.59	-0.31
Diluted EPS Before Extra, 2 Yr. CAGR %	15.17	24.59	-14.04	11.23	22.33
Accounts Receivable, 2 Yr. CAGR %	21.62	12.52	8.94	7.94	3.51
Inventory, 2 Yr. CAGR %	31.74	-30.14	6.2	12.72	4.56
Net Property, Plant and Equip., 2 Yr. CAGR %	15.83	0.09	5.27	7.39	5.75
Total Assets, 2 Yr. CAGR %	84.03	-8.28	-9.6	-6.7	-2.2
Tangible Book Value, 2 Yr. CAGR %	137.03	-11.86	-15.07	-16.66	5.15
Common Equity, 2 Yr. CAGR %	64.18	-16.53	-9.38	-9.52	-27.48
Cash From Operations, 2 Yr. CAGR %	41.02	40.5	-3.57	-7.52	7.82
Capital Expenditures, 2 Yr. CAGR %	-11.02	7.88	21.85	11.47	5.65
Levered Free Cash Flow, 2 Yr. CAGR %	155	58.07	0.54	3.81	12.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	156.83	54.9	0.02	3.27	13.37
Dividend Per Share, 2 Yr. CAGR %	6.9	9.38	9.1	7.2	5.12
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	26.96	27.16	20.86	1.91	1.36
Gross Profit, 3 Yr. CAGR %	31.68	31.88	25.86	3.9	-0.09
EBITDA, 3 Yr. CAGR %	58.54	51.93	37.25	10.04	0.13
EBITA, 3 Yr. CAGR %	61.76	54.06	38.45	10.33	0.11
EBIT, 3 Yr. CAGR %	24.88	23	17.58	36.64	4.68
Earnings From Cont. Operations, 3 Yr. CAGR %	109.73	12.34	22.4	-3.67	8.4
Net Income, 3 Yr. CAGR %	107.64	12.44	22.53	-3.8	8.56
Normalized Net Income, 3 Yr. CAGR %	13.91	16.69	14.63	39.55	2.25
Diluted EPS Before Extra, 3 Yr. CAGR %	87.06	1.2	13.64	-1.12	12.26
Accounts Receivable, 3 Yr. CAGR %	14.87	19.19	10.58	9	4.59
Inventory, 3 Yr. CAGR %	21.16	20.58	-18.32	8.68	6.87
Net Property, Plant and Equip., 3 Yr. CAGR %	10.49	11.5	2.43	6.01	6.26
Total Assets, 3 Yr. CAGR %	52.28	46.19	-9.34	-7.05	-5.38
Tangible Book Value, 3 Yr. CAGR %	114.04	61.73	-9.37	-19.43	1.94
Common Equity, 3 Yr. CAGR %	47.69	36.83	-15.56	-8.02	-23.12
Cash From Operations, 3 Yr. CAGR %	38.62	31.88	16.75	-0.46	-2.14
Capital Expenditures, 3 Yr. CAGR %	-10.63	0.77	10.17	17.1	8.65
Levered Free Cash Flow, 3 Yr. CAGR %	97.47	75.21	36.56	0.23	9.72
Unlevered Free Cash Flow, 3 Yr. CAGR %	97.17	76.43	34.41	-0.1	10.02
Dividend Per Share, 3 Yr. CAGR %	5.43	7.68	9.24	7.88	6.38
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	20.75	19.01	17.31	14.81	13.06
Gross Profit, 5 Yr. CAGR %	21.73	20.67	19.53	16.38	14.78
EBITDA, 5 Yr. CAGR %	32.6	29.23	34.6	25.71	20
EBITA, 5 Yr. CAGR %	34.23	30.13	36.25	26.66	20.62
EBIT, 5 Yr. CAGR %	14.92	13.62	19.94	10.39	10.1
Earnings From Cont. Operations, 5 Yr. CAGR %	40.7	9.25	45.44	10.2	20.89
Net Income, 5 Yr. CAGR %	41.94	9.43	44.42	10.28	21.08
Normalized Net Income, 5 Yr. CAGR %	13.52	11.23	14.45	9	6.88
Diluted EPS Before Extra, 5 Yr. CAGR %	33.83	3.32	37.06	5.1	17.04
Accounts Receivable, 5 Yr. CAGR %	16.83	14.63	13.12	14.55	7.69
Inventory, 5 Yr. CAGR %	11.18	11.04	14.94	17.37	-9.84
Net Property, Plant and Equip., 5 Yr. CAGR %	8.86	6.95	8.37	9.84	3.75
Total Assets, 5 Yr. CAGR %	30.13	26.53	23.61	22.16	-6.55
Tangible Book Value, 5 Yr. CAGR %	43.23	27.89	47.89	24.06	-3.82
Common Equity, 5 Yr. CAGR %	21.53	17.31	21.48	15.97	-20.55
Cash From Operations, 5 Yr. CAGR %	46.18	39.59	19.89	14.42	13.09
Capital Expenditures, 5 Yr. CAGR %	-1.69	-4.35	1.17	4.92	8.34
Levered Free Cash Flow, 5 Yr. CAGR %	37.66	57.26	45.37	40.42	25.46
Unlevered Free Cash Flow, 5 Yr. CAGR %	38.13	56.83	45.22	40.83	24.75
Dividend Per Share, 5 Yr. CAGR %	4.31	5.61	6.88	7.49	7.57